World's Best Scientists 2026 revealed!
Cornelis van 't Veer

Cornelis van 't Veer

D-Index & Metrics

Immunology

D-Index
55
Citations
10530
World Ranking
3810
National Ranking
145

Cornelis van 't Veer publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Cornelis van 't Veer sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 187 publications — 30th percentile

30% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Cornelis van 't Veer D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Cornelis van 't Veer sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 55 D-Index — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Cornelis van 't Veer is affiliated with the University of Amsterdam in the Netherlands. Their research spans multiple fields including Medicine, Biochemistry, Genetics and Molecular Biology, and Immunology and Microbiology. Within these broader fields, Cornelis has contributed extensively to subfields such as Immunology, Molecular Biology, Hematology, Epidemiology, and Infectious Diseases.

Their work primarily focuses on topics related to immune response and inflammation, trauma, hemostasis, coagulopathy and resuscitation, platelet disorders and treatments, atrial fibrillation management and outcomes, blood coagulation and thrombosis mechanisms, COVID-19 clinical research studies, and venous thromboembolism diagnosis and management.

Cornelis van 't Veer has published in various academic venues. Frequent publication venues include:

  • Frontiers in Immunology
  • Journal of Thrombosis and Haemostasis
  • Research and Practice in Thrombosis and Haemostasis
  • Transfusion
  • Thrombosis and Haemostasis

Among recent publications are:

  • Platelet dysfunction after trauma: From mechanisms to targeted treatment, 2022, Transfusion
  • Platelets are Hyperactivated but Show Reduced Glycoprotein VI Reactivity in COVID-19 Patients, 2021, Thrombosis and Haemostasis
  • HIVEP1 Is a Negative Regulator of NF-κB That Inhibits Systemic Inflammation in Sepsis, 2021, Frontiers in Immunology
  • The GPCR adaptor protein norbin suppresses the neutrophil-mediated immunity of mice to pneumococcal infection, 2021, Blood Advances
  • Caspase-11 contributes to pulmonary host defense against Klebsiella pneumoniae and local activation of coagulation, 2020, American Journal of Physiology-Lung Cellular and Molecular Physiology

Frequent collaborators in research include Tom van der Poll, Alex F. de Vos, W. Joost Wiersinga, Brendon P. Scicluna, and Osoul Chouchane. These coauthors have worked jointly with Cornelis on various studies, reflecting ongoing research partnerships.

Best Publications

  • Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation

    Marc A.R.C. Daemen;Cornelis van ‘t Veer;Geertrui Denecker;Vincent H. Heemskerk

  • In vivo expression of Toll-like receptor 2 and 4 by renal epithelial cells: IFN-gamma and TNF-alpha mediated up-regulation during inflammation.

    Tim G. A. M. Wolfs;Wim A. Buurman;Annemarie van Schadewijk;Bart de Vries

  • TAM receptors, Gas6, and protein S: roles in inflammation and hemostasis

    Jonathan H. M. van der Meer;Tom van der Poll;Cornelis van ‘t Veer

  • Toll-Like Receptor 2 Plays a Role in the Early Inflammatory Response to Murine Pneumococcal Pneumonia but Does Not Contribute to Antibacterial Defense

    Sylvia Knapp;Catharina W. Wieland;Cornelis van ’t Veer;Osamu Takeuchi

  • The role of platelets in sepsis

    Sacha F de Stoppelaar;Cornelis van 't Veer;Tom van der Poll

  • Lipopolysaccharide (LPS)-binding protein mediates LPS detoxification by chylomicrons.

    Anita C. E. Vreugdenhil;Corine H. Rousseau;Thomas Hartung;Jan Willem M. Greve

  • Thrombocytopenia impairs host defense in gram-negative pneumonia–derived sepsis in mice

    Sacha F. de Stoppelaar;Cornelis van ’t Veer;Theodora A. M. Claushuis;Bregje J. A. Albersen

  • Induction of IRAK-M Is Associated with Lipopolysaccharide Tolerance in a Human Endotoxemia Model

    Cornelis van ‘t Veer;Petra S. van den Pangaart;Marieke A. D. van Zoelen;Martijn de Kruif

  • Leptin and Soluble Leptin Receptor Levels in Obese and Weight-Losing Individuals

    Francois M. H. van Dielen;Cornelis van ‘t Veer;Wim A. Buurman;Jan Willem M. Greve

  • Asthma and coagulation.

    J. Daan de Boer;Christof J. Majoor;Cornelis van 't Veer;Elisabeth H. D. Bel

  • LPS-binding protein circulates in association with apoB-containing lipoproteins and enhances endotoxin-LDL/VLDL interaction

    Anita C.E. Vreugdenhil;A.M. Patricia Snoek;Cornelis van ‘t Veer;Jan-Willem M. Greve

  • Targeting CD40-Induced TRAF6 Signaling in Macrophages Reduces Atherosclerosis

    Tom T.P. Seijkens;Claudia M. van Tiel;Pascal J.H. Kusters;Dorothee Atzler

  • Inhibition of thrombin generation by the zymogen factor VII: implications for the treatment of hemophilia A by factor VIIa

    Cornelis van 't Veer;Neal J. Golden;Kenneth G. Mann

  • Matrix metalloproteinase-9 deficiency impairs host defense against abdominal sepsis.

    Rosemarijn Renckens;Joris J. T. H. Roelofs;Sandrine Florquin;Alex F. de Vos

  • A Tick Mannose-Binding Lectin Inhibitor Interferes with the Vertebrate Complement Cascade to Enhance Transmission of the Lyme Disease Agent

    Tim J. Schuijt;Tim J. Schuijt;Tim J. Schuijt;Jeroen Coumou;Jeroen Coumou;Sukanya Narasimhan;Jianfeng Dai

  • Myeloid-related protein-14 contributes to protective immunity in gram-negative pneumonia derived sepsis

    Ahmed Achouiti;Thomas Vogl;Constantin F. Urban;Marc Röhm

  • High-Density Lipoprotein Attenuates Inflammation and Coagulation Response on Endotoxin Challenge in Humans

    Rakesh S. Birjmohun;Sander I. van Leuven;Johannes H.M. Levels;Cornelis van ‘t Veer

  • Plasminogen activator inhibitor type 1 is protective during severe Gram-negative pneumonia.

    Rosemarijn Renckens;Joris J T H Roelofs;Peter I Bonta;Sandrine Florquin

  • In Vivo Lipopolysaccharide Exposure of Human Blood Leukocytes Induces Cross-Tolerance to Multiple TLR Ligands

    Alex F. de Vos;Jennie M. Pater;Petra S. van den Pangaart;Martijn D. de Kruif

  • Role of Peptidylarginine Deiminase 4 in Neutrophil Extracellular Trap Formation and Host Defense during Klebsiella pneumoniae- Induced Pneumonia-Derived Sepsis.

    Theodora A. M. Claushuis;Lieve E. H. van der Donk;Anna L. Luitse;Henk A. van Veen

  • Antiplatelet agents in tissue factor–induced blood coagulation

    Saulius Butenas;Kevin M. Cawthern;Cornelis van't Veer;Maria E. DiLorenzo

Frequent Co-Authors

Tom van der Poll
Tom van der Poll University of Amsterdam
Alex F. de Vos
Alex F. de Vos University of Amsterdam
Joris J. T. H. Roelofs
Joris J. T. H. Roelofs University of Amsterdam
Sandrine Florquin
Sandrine Florquin University of Amsterdam
Joost C. M. Meijers
Joost C. M. Meijers University of Amsterdam
Marcel Levi
Marcel Levi University of Amsterdam
Wim A. Buurman
Wim A. Buurman Maastricht University
Kenneth G. Mann
Kenneth G. Mann University of Vermont
Arjen M. Dondorp
Arjen M. Dondorp Mahidol Oxford Tropical Medicine Research Unit
Marcus J. Schultz
Marcus J. Schultz University of Amsterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in immunology often intersects with various healthcare fields, especially nursing specializations that complement immunological research and patient care. For those interested in advancing their qualifications, exploring the easiest np program options can provide a great starting point for transitioning into advanced clinical roles with manageable coursework.

Mental health is an important facet closely related to immunology, particularly in understanding autoimmune diseases and neuroimmunology. Many professionals turn to specialized certifications like the top pmhnp programs to gain expertise and secure strong clinical placements. Affordability is also a major consideration, and the cheapest pmhnp certificate programs offer pathways that balance cost and quality education effectively.

For career advancement, Doctor of Nursing Practice (DNP) graduates can look into salary potentials that vary by location. The dnp salary by state data helps prospective students and professionals make informed decisions about where to practice and maximize their earning power.

Overall, integrating immunology studies with nursing and psychiatric degrees expands career options, offering promising job prospects in clinical and research environments.

Best Scientists Citing Cornelis van 't Veer

Trending Scientists